Today: 17 May 2026
PLS Group share price drops nearly 7% as lithium sector pulls back after risk-off jolt
3 March 2026
1 min read

PLS Group share price drops nearly 7% as lithium sector pulls back after risk-off jolt

Sydney, March 3, 2026, 18:14 (AEDT) — Trading after hours.

PLS Group Limited dropped 6.8% to finish at A$4.80 on Tuesday, breaking a brief upswing and slipping under A$5 again. Even with this pullback, the lithium miner has climbed roughly 153% in the last year, thanks to a rally that kicked off in late 2025.

Investors dialed down positions in riskier assets after U.S. and Israeli attacks on Iran sent oil prices climbing, pressing fresh on inflation fears. “Economic policy uncertainty was already elevated and now with the Iran conflict, the geopolitical risk is expected to rise too,” said Rupal Agarwal, an Asia quant strategist at Bernstein in Singapore. Reuters

On the domestic front, nerves around rates piled on. Reserve Bank of Australia Governor Michele Bullock said a rate hike could come as early as March, speaking at a Sydney business summit. “I’m not making a prediction about March but it will be a live meeting,” Bullock said. Reuters

PLS kicked off the session at A$5.14, climbed to A$5.20 early, then drifted down to A$4.71 at its lowest, Yahoo Finance figures show. Roughly 16.8 million shares traded. The closing price settled at A$4.805 on that platform.

The rout wasn’t limited to just one name. Mineral Resources tumbled roughly 6.1%, IGO shed close to 6.0%, and Liontown plunged around 9.0%, by Intelligent Investor’s tally.

Commodity prices weighed on the market. Chinese benchmark lithium dropped to roughly 161,000 yuan per tonne on March 3, a 6.7% slide from the previous day, according to Trading Economics. Lithium carbonate, essential for battery production, continued to see pressure.

Zimbabwe’s abrupt ban on exports of raw minerals and lithium concentrates late last month rattled the lithium market, with officials blaming smuggling and irregularities. The decision has thrown up new uncertainties around lithium shipments to China.

Australian shares took a sharp hit Tuesday, the ASX 200 falling 1.34% as losses in miners and gold stocks erased their previous day’s advances.

Still, PLS’s trajectory might not be straightforward from here. Should lithium chemical prices continue to fall while oil holds up—leaving rate expectations elevated—higher-beta miners could remain on the back foot, even absent fresh company updates.

PLS has its next quarterly update scheduled for April 16, according to a calendar listing.

Stock Market Today

  • Realty Income (O) Faces Mixed Valuation Signals After Solid Q1 and Raised AFFO Guidance
    May 17, 2026, 12:49 AM EDT. Realty Income (O) reported strong Q1 results and boosted its Adjusted Funds From Operations (AFFO) guidance, alongside its 671st monthly dividend, equity issuance, and buybacks. Despite these positive developments, its share price fell 6.1% over 30 days and 6.9% over 90 days. The stock trades at a high price-to-earnings (P/E) ratio of 50.9x, well above peer averages, suggesting valuation risk. However, a dividend-focused valuation model indicates the stock is 13.8% undervalued with a fair value of $70.93 compared to the current $61.12 share price. Investors should weigh steady dividend growth and operating margins against rising funding costs and regional revenue risks in Realty Income's western markets.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Westpac share price holds at A$41.80 as RBA flags March hike risk and GDP looms
Previous Story

Westpac share price holds at A$41.80 as RBA flags March hike risk and GDP looms

Lloyds share price drops again as oil shock hits UK banks ahead of Reeves update
Next Story

Lloyds share price drops again as oil shock hits UK banks ahead of Reeves update

Go toTop